US 12,246,076 B2
Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disorders
Kuo-Shyan Lin, Richmond (CA); François Bénard, Vancouver (CA); Lei Wang, Vancouver (CA); Zhengxing Zhang, Langley (CA); Ivica Bratanovic, Port Moody (CA); and Chengcheng Zhang, Richmond (CA)
Assigned to PROVINCIAL HEALTH SERVICES AUTHORITY, Vancouver (CA); and THE UNIVERSITY OF BRITISH COLUMBIA, Vancouver (CA)
Filed by PROVINCIAL HEALTH SERVICES AUTHORITY, Vancouver (CA); and THE UNIVERSITY OF BRITISH COLUMBIA, Vancouver (CA)
Filed on Nov. 17, 2023, as Appl. No. 18/512,708.
Application 18/512,708 is a continuation of application No. PCT/CA2023/050401, filed on Mar. 24, 2023.
Claims priority of provisional application 63/323,831, filed on Mar. 25, 2022.
Prior Publication US 2024/0123099 A1, Apr. 18, 2024
Int. Cl. A61K 51/00 (2006.01); A61K 51/08 (2006.01); A61M 36/14 (2006.01)
CPC A61K 51/088 (2013.01) [A61K 2121/00 (2013.01); A61K 2123/00 (2013.01)] 14 Claims
 
1. A peptidic compound having the structure: optionally complexed with a radiometal:

OG Complex Work Unit Chemistry
or a salt or a solvate thereof.